InvestorsHub Logo
Followers 9
Posts 750
Boards Moderated 0
Alias Born 10/19/2008

Re: thefamilyman post# 4836

Tuesday, 03/18/2014 9:39:21 AM

Tuesday, March 18, 2014 9:39:21 AM

Post# of 6599
Great to see the steady upward trend on revenues.

I think their cell culture media might drive the majority of revenue increases in the future.

I think they will still have to dilute some to get operating capital as their G&A is a little high and the revenues will still need to climb somewhat before they actually start paying for R&D.

I hope they can keep total outstanding shares to 200 million, or 250 million tops. I also hope they can get the Parkinsons treatment results out there in a good way to allow for a higher share price in any future offering. They could probably raise enough funds for another 12months in the bank and keep at or below the 200 million outstanding share count. Based on other companies statistics and the great news on the Parkinsons efficacy, my personal opinion is the capitalization value should be at 200 million at least this year. That would be around a $1/share. When the IND is in place, 400million, $2per share and with good results, whcih the primate studies are suggesting will likely happen, well up from there substantially.

All in all, I agree the stock is undervalued and is a BUY IMO.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ISCO News